Evidence map›Paper›PMID 42775042›Full record

ReviewFrontiers in cell and developmental biology2026

Toward trustworthy virtual cells: a roadmap for perturbation-resolved, context-aware, and experimentally validated cell models.

Wangshu Li, Aziz Ur Rehman Aziz, Bowen Xu, Jingshan Xu, Xiaohui Yu, Daqing Wang, Chunfang Ha

Abstract readReview
In one paragraph

Review in Frontiers in cell and developmental biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Wangshu Li *Key Laboratory of Biotherapy, Dalian Women and Children's Medical Center Group, Women and Children's Hospital Affiliated to Dalian University of Technology, Dalian, Liaoning, China.
Aziz Ur Rehman Aziz *Key Laboratory of Biotherapy, Dalian Women and Children's Medical Center Group, Women and Children's Hospital Affiliated to Dalian University of Technology, Dalian, Liaoning, China.
Bowen XuKey Laboratory of Biotherapy, Dalian Women and Children's Medical Center Group, Women and Children's Hospital Affiliated to Dalian University of Technology, Dalian, Liaoning, China.
Jingshan XuBengbu Medical University, Bengbu, China.
Xiaohui YuKey Laboratory of Biotherapy, Dalian Women and Children's Medical Center Group, Women and Children's Hospital Affiliated to Dalian University of Technology, Dalian, Liaoning, China.
Daqing WangKey Laboratory of Biotherapy, Dalian Women and Children's Medical Center Group, Women and Children's Hospital Affiliated to Dalian University of Technology, Dalian, Liaoning, China.
Chunfang HaGeneral Hospital of Ningxia Medical University, Yinchuan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Single-cell perturbation technologies, multimodal omics, spatial profiling, and generative modeling are transforming the virtual cell from a theoretical concept into a practical objective for cell biology. Yet current efforts often emphasize model scale, data volume, or predictive breadth, while the trustworthiness required for scientific and translational use remains insufficiently addressed. We argue that virtual-cell models become decision-relevant only when the evidential chain connecting data, model design, benchmarking, and experimental validation is made explicit. We introduce the trustworthy virtual cell, a perturbation-resolved, context-aware, and experimentally validated system capable of supporting biological inference, experimental design, and preclinical decision-making. We organize recent progress around four empirical layers, namely, molecular cell state, intervention, biological context, and orthogonal phenotype, complemented by structured priors. This framework explains why static atlases, transcriptome-only readouts, and in-distribution benchmarks are insufficient for predicting cellular behavior under new conditions. Across mechanistic, deep generative, foundation, and hybrid models, we discuss trade-offs among interpretability, scalability, and extrapolation. We further argue that evaluation should move beyond held-out reconstruction accuracy toward biologically meaningful criteria, including generalization to unseen cell types and perturbations, dose, time, and combination response extrapolation, uncertainty calibration, and mechanistic consistency. We then propose a closed-loop validation ladder connecting

Indexed as

model validationmultimodal integrationsingle-cell perturbationstrustworthy AIvirtual cells

Identifiers

PMID42775042
PMCPMC13595059

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.